Total Payments
$195,234
2024 Payments
$29,031
Companies
84
Transactions
2,314
Medicare Patients
2,581
Medicare Billing
$883,712
Payment Breakdown by Category
Other$134,078 (68.7%)
Food & Beverage$33,754 (17.3%)
Consulting$21,041 (10.8%)
Travel$6,198 (3.2%)
Education$162.41 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $134,078 | 76 | 68.7% |
| Food and Beverage | $33,754 | 2,186 | 17.3% |
| Consulting Fee | $21,041 | 12 | 10.8% |
| Travel and Lodging | $6,198 | 32 | 3.2% |
| Education | $162.41 | 8 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $147,780 | 254 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $13,389 | 129 | $0 (2022) |
| ABBVIE INC. | $8,888 | 251 | $0 (2024) |
| UCB, Inc. | $1,856 | 116 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,609 | 125 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $1,527 | 178 | $0 (2024) |
| Allergan, Inc. | $1,438 | 113 | $0 (2022) |
| GENZYME CORPORATION | $1,375 | 66 | $0 (2023) |
| Amgen Inc. | $1,153 | 79 | $0 (2024) |
| Lundbeck LLC | $1,066 | 60 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $29,031 | 313 | Biogen, Inc. ($18,091) |
| 2023 | $15,216 | 322 | Biogen, Inc. ($10,873) |
| 2022 | $24,406 | 382 | Biogen, Inc. ($19,483) |
| 2021 | $17,473 | 307 | Biogen, Inc. ($13,892) |
| 2020 | $15,667 | 216 | Biogen, Inc. ($12,926) |
| 2019 | $23,745 | 274 | Biogen, Inc. ($20,201) |
| 2018 | $46,552 | 334 | Biogen, Inc. ($30,982) |
| 2017 | $23,145 | 166 | Biogen, Inc. ($21,333) |
All Payment Transactions
2,314 individual payment records from CMS Open Payments — Page 1 of 93
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $29.46 | General |
| Category: Rare Disease | ||||||
| 12/20/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $12.09 | General |
| Category: NEUROLOGY | ||||||
| 12/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $10.46 | General |
| Category: PAIN | ||||||
| 12/18/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $6.11 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/17/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: Neurology | ||||||
| 12/17/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/17/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $5.79 | General |
| Category: Central Nervous System | ||||||
| 12/12/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: Immunology | ||||||
| 12/11/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $12.11 | General |
| Category: Neurology | ||||||
| 12/09/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: Musculoskeletal | ||||||
| 12/09/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $4.45 | General |
| Category: Neurology | ||||||
| 12/09/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $4.21 | General |
| Category: Neurology | ||||||
| 12/09/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $4.14 | General |
| Category: Neurology | ||||||
| 12/06/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: Neuropsychiatry | ||||||
| 12/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $10.67 | General |
| Category: PAIN | ||||||
| 12/04/2024 | Amneal Pharmaceuticals LLC | ONGENTYS (Drug) | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: NEUROLOGY | ||||||
| 12/03/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: Central Nervous System | ||||||
| 12/03/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $8.79 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/26/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $15.32 | General |
| Category: NEUROLOGY | ||||||
| 11/26/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $2.80 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/25/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $25.71 | General |
| Category: Neurology | ||||||
| 11/25/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: NEUROSCIENCE | ||||||
| 11/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $19.13 | General |
| Category: NEUROLOGY | ||||||
| 11/21/2024 | Genentech USA, Inc. | Ocrevus Zunovo (Biological) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 622 | 33,733 | $509,453 | $238,846 |
| 2022 | 9 | 671 | 37,543 | $564,307 | $258,710 |
| 2021 | 9 | 650 | 25,930 | $445,536 | $208,499 |
| 2020 | 10 | 638 | 23,529 | $388,674 | $177,656 |
Total Patients
2,581
Total Services
120,735
Medicare Billing
$883,712
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 50 | 32,955 | $329,550 | $162,719 | 49.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 361 | 437 | $80,408 | $35,794 | 44.5% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 51 | 167 | $48,263 | $18,448 | 38.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 49 | 57 | $14,613 | $7,218 | 49.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 30 | 30 | $9,930 | $4,440 | 44.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 42 | 42 | $10,920 | $4,394 | 40.2% |
| 99483 | Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | Office | 2023 | 16 | 16 | $8,960 | $2,666 | 29.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 12 | 12 | $3,936 | $1,606 | 40.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 17 | $2,873 | $1,561 | 54.3% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 66 | 36,710 | $367,100 | $177,061 | 48.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 327 | 411 | $75,624 | $32,349 | 42.8% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 67 | 190 | $54,910 | $19,967 | 36.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 74 | 83 | $21,295 | $10,164 | 47.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 41 | 41 | $13,571 | $6,195 | 45.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 54 | 54 | $14,040 | $5,976 | 42.6% |
| 99483 | Assessment of and care planning for impaired thought processing, typically 50 minutes | Office | 2022 | 16 | 16 | $8,960 | $3,051 | 34.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 15 | 15 | $4,920 | $2,210 | 44.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 11 | 23 | $3,887 | $1,737 | 44.7% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 43 | 25,061 | $250,610 | $120,000 | 47.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 328 | 421 | $73,544 | $34,577 | 47.0% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Office | 2021 | 44 | 143 | $40,907 | $16,286 | 39.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 37 | 96 | $15,844 | $7,709 | 48.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 48 | 48 | $15,432 | $7,264 | 47.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 44 | 55 | $13,351 | $6,981 | 52.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 56 | 56 | $14,404 | $6,845 | 47.5% |
About Dr. Aaron Farrow, MD
Dr. Aaron Farrow, MD is a Neurology healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/11/2010. The National Provider Identifier (NPI) number assigned to this provider is 1376864439.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Aaron Farrow, MD has received a total of $195,234 in payments from pharmaceutical and medical device companies, with $29,031 received in 2024. These payments were reported across 2,314 transactions from 84 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($134,078).
As a Medicare-enrolled provider, Farrow has provided services to 2,581 Medicare beneficiaries, totaling 120,735 services with total Medicare billing of $883,712. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Oklahoma City, OK
- Active Since 06/11/2010
- Last Updated 06/11/2010
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1376864439
Products in Payments
- VUMERITY (Drug) $43,041
- TYSABRI (Biological) $42,976
- TECFIDERA (Drug) $40,631
- TROKENDI XR (Drug) $13,066
- QULIPTA (Drug) $7,393
- Tysabri (Biological) $3,737
- BOTOX (Biological) $1,527
- NURTEC ODT (Drug) $1,139
- KESIMPTA (Drug) $1,021
- APTIOM (Drug) $987.78
- Briviact (Drug) $968.73
- Aimovig (Biological) $960.38
- UBRELVY (Drug) $824.67
- AUBAGIO (Drug) $803.18
- VYEPTI (Biological) $775.05
- NUPLAZID (Drug) $749.90
- AJOVY (Biological) $683.46
- Xeomin (Biological) $566.88
- Trudhesa (Drug) $505.42
- RYTARY (Drug) $490.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Oklahoma City
Dr. Cherian Karunapuzha, Md, MD
Neurology — Payments: $4.3M
Neurology $4.3M
Gabriel Pardo, M.d, M.D
Neurology — Payments: $1.6M
Neurology $1.6M
Marguerite Butchee, Md, MD
Neurology — Payments: $254,555
Neurology $254,555
Chelsea Berkley, Md, MD
Neurology — Payments: $228,923
Neurology $228,923
Ashish Masih, M.d, M.D
Neurology — Payments: $153,184
Neurology $153,184
Christi Pendergraft, Md, MD
Neurology — Payments: $95,478
Neurology $95,478